检索结果 - L. Seigel
- Showing 1 - 3 results of 3
-
1
-
2
-
3
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, plac... 由 Sung‐Bae Kim, Rebecca Dent, Seock‐Ah Im, Marc Espié, Sibel Blau, Antoinette R. Tan, Steven J. Isakoff, Mafalda Oliveira, Cristina Saura, Matthew Wongchenko, Amy V. Kapp, Wai Yee Chan, Stina Mui Singel, Daniel Maslyar, José Baselga, Sungbae Kim, Keun Seok Lee, Seock‐Ah Im, Marc Espié, Hwei-Chung Wang, Sibel Blau, Rebecca Dent, Antoinette R. Tan, Joohyuk Sohn, Michelino De Laurentiis, Laura García‐Estévez, Chiun‐Sheng Huang, Gilles Romieu, Michel Velez, Rafael Villanueva-Vázquez, Pierfranco Conté, Shaker R. Dakhil, Marc Debled, Antonio González-Martı́n, Sara A. Hurvitz, Jee Hyun Kim, Christelle Lévy, Mafalda Oliveira, Pedro Sánchez‐Rovira, Jae Hong Seo, Vicente Valero, Gregory A. Vidal, Andrea Wong, Mary Ann Allison, Robert A. Figlin, David Chan, Shin‐Cheh Chen, Yen‐Hsun Chen, Melody A. Cobleigh, Filippo de Braud, Luc Dirix, Vincent Hansen, Anne Hardy Bessard, Nicholas Iannotti, Steven J. Isakoff, William Lawler, Álvaro Montaño, Mohamad Salkini, L. Seigel
出版 2017Artigo
相关主题
Internal medicine
Medicine
Surgery
Cancer
Chemotherapy
Oncology
Adjuvant therapy
Alternative medicine
Aorta
Aortography
Artery
Asymptomatic
Breast cancer
Carboplatin
Cardiology
Celiac artery
Cisplatin
Clinical endpoint
Clinical trial
Confidence interval
Environmental health
Epidermal growth factor receptor
Erlotinib
Erlotinib Hydrochloride
Gastroenterology
Hazard ratio
Inferior mesenteric artery
Ischemia
Lung cancer
Mesenteric arteries